Syneos Health Inc - Company Profile
Powered by 
All the sales intelligence you need on Syneos Health Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Syneos Health Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Syneos Health Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
The following section provides information on Syneos Health Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Syneos Health Inc's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
Colin Shannon
Chairman Executive BoardMr. Colin Shannon has the Chairman of the company since October 2024. Previously, he served as the Chief Executive Officer and Director of the company. Prior to this, he was the Chairman and Chief Executive Officer of PRA Health Sciences, Inc.
Costa Panagos
Chief Executive Officer Senior ManagementMr Costa Panagos has been the Chief Executive Officer of the company since 2024. Prior to this, he served as the President, Research & Development Solutions at IQVIA. Previously, he served in operational and executive leadership roles, including serving as the CEO at Q2 Solutions.
Michael Bonello
Chief Financial Officer Senior ManagementMr. Michael Bonello has been the Chief Financial Officer of the company since July 2023. Prior to this, he served as the Chief Financial Officer at Clario, Inc. Previously, he served as the Executive Vice President and Chief Financial Officer at PRA Health Sciences, Inc. He held financial leadership roles at Cree, Inc. and Genworth Financial.
Michael Brooks
Chief Operating Officer Senior ManagementMr. Michael Brooks has been the Chief Operating Officer of the company since April 2022. Prior to this he served as a Chief Development Officer and Global Head Clinical Development Solutions from 2021 to 2022.
Greg Licholai, MD
Chief Medical Officer Senior ManagementMr. Greg Licholai has been the Chief Medical Officer of the company since June 2026. Previously, he served as Chief Medical and Innovation Officer at ICON. Prior to this, he served as President of Rare Disease at Moderna. Prior to that, He worked at McKinsey & Company.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer